| # | Drug | Count |
|---|---|---|
| 0 | ETOPOSIDE | 17 |
| 1 | ATEZOLIZUMAB | 12 |
| 2 | CARBOPLATIN | 12 |
| 3 | METHOTREXATE | 10 |
| 4 | METHOTREXATE SODIUM | 10 |
| 5 | CISPLATIN | 9 |
| 6 | ALBUTEROL SULFATE | 6 |
| 7 | ETANERCEPT | 6 |
| 8 | INFLIXIMAB | 6 |
| 9 | ONDANSETRON HYDROCHLORIDE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOPOTECAN HYDROCHLORIDE | 3 | 0.0012 |
| 1 | ESTAZOLAM | 1 | 0.0005 |
| 2 | AMINOPHYLLINE | 1 | 0.0005 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 2 | 0.0004 |
| 4 | PEGFILGRASTIM | 5 | 0.0004 |
| 5 | AMIFAMPRIDINE PHOSPHATE | 1 | 0.0003 |
| 6 | TOPOTECAN | 2 | 0.0003 |
| 7 | ERLOTINIB HYDROCHLORIDE | 4 | 0.0003 |
| 8 | ATEZOLIZUMAB | 12 | 0.0003 |
| 9 | DEXAMETHASONE SODIUM PHOSPHATE | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 2 | Topoisomerase Inhibitor [EPC] | 18 | 0.0002 |
| 3 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 12 | 0.0001 |
| 5 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 6 | Platinum-based Drug [EPC] | 20 | 0.0001 |
| 7 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 8 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |